1 – 10 of 22
      - show: 10
- |
- sort: year (new to old)
        Close
        
            
    
    Embed this list
<iframe src=""
              width=""
              height=""
              allowtransparency="true"
              frameborder="0">
            </iframe>
        - 2026
- 
                        Mark
        DAPAgliflozin for renal protection in heart transplant recipients. Rationale and design of the randomized controlled DAPARHT trial
    
    - Contribution to journal › Article
 
- 2024
- 
                        Mark
        Long-term follow-up of the randomized, prospective Scandinavian heart transplant everolimus de novo study with early calcineurin inhibitors avoidance (SCHEDULE) trial
    
    - Contribution to journal › Article
 
- 
                        Mark
        The Effect of Everolimus Versus Calcineurin Inhibitors on Quality of Life 10–12 Years After Heart Transplantation : The Results of a Randomized Controlled Trial (SCHEDULE Trial)
    
    - Contribution to journal › Article
 
- 
                        Mark
        Randomized Trial of Cholesterol Lowering With Evolocumab for Cardiac Allograft Vasculopathy in Heart Transplant Recipients
    
    - Contribution to journal › Article
 
- 2022
- 
                        Mark
        Healthcare resource use of patients with transthyretin amyloid cardiomyopathy
    
    - Contribution to journal › Article
 
- 
                        Mark
        Prevalence, characteristics, and mortality of patients with transthyretin amyloid cardiomyopathy in the Nordic countries
    
    - Contribution to journal › Article
 
- 2021
- 
                        Mark
        Nationwide prevalence and characteristics of transthyretin amyloid cardiomyopathy in Sweden
    
    - Contribution to journal › Article
 
- 2020
- 
                        Mark
        Mild acute cellular rejection and development of cardiac allograft vasculopathy assessed by intravascular ultrasound and coronary angiography in heart transplant recipients—a SCHEDULE trial substudy
    
    - Contribution to journal › Article
 
- 
                        Mark
        Everolimus Initiation With Early Calcineurin Inhibitor Withdrawal in De Novo Heart Transplant Recipients : Long-term Follow-up From the Randomized SCHEDULE Study
    
    - Contribution to journal › Article
 
- 
                        Mark
        Invasive haemodynamics in de novo everolimus vs. calcineurin inhibitor heart transplant recipients
    
    - Contribution to journal › Article
 
